{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:42:54Z","timestamp":1792813374795,"version":"4.5.0"},"reference-count":37,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The Prostate"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Whole\u2010gland (WG) prostate\u2010specific antigen (PSA) density (PSAD) has proven useful in diagnosing to be beneficial in localized prostate cancer (PCa). This study aimed to evaluate the predictive performance of WG and zonal (transition zone [TZ] and peripheral zone [PZ]) PSAD in predicting PCa and clinically significant PCa (csPCa) in prostate MRI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A retrospective analysis was conducted on consecutive patients who underwent multiparametric MRI and MRI\/US fusion\u2010guided biopsy between March 2019 and July 2024. TZ\u2010PSAD, PZ\u2010PSAD, and WG\u2010PSAD were calculated using in\u2010house AI models. Optimal thresholds for TZ\u2010PSAD and PZ\u2010PSAD were determined using the Youden index from receiver operating characteristic (ROC) curve analyses with five\u2010fold cross\u2010validation, whereas 0.15\u2009ng\/mL\n                      <jats:sup>2<\/jats:sup>\n                      was applied as the threshold for WG\u2010PSAD. Statistical comparisons were performed using Wilcoxon rank\u2010sum,\n                      <jats:italic>\u03c7<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      , and Fisher's exact tests. Logistic regression (LR) and area under the ROC curve (AUC) analyses with DeLong's test were conducted to evaluate diagnostic performance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study cohort included 774 consecutive patients (median age\u2009=\u200967 years [interquartile range {IQR}: 61\u201371], median WG\u2010PSAD\u2009=\u20090.11\u2009ng\/mL\n                      <jats:sup>2<\/jats:sup>\n                      [IQR: 0.07\u20130.17], median TZ\u2010PSAD\u2009=\u20090.22\u2009ng\/mL\n                      <jats:sup>2<\/jats:sup>\n                      [IQR: 0.12\u20130.41], median PZ\u2010PSAD\u2009=\u20090.13\u2009ng\/mL\n                      <jats:sup>2<\/jats:sup>\n                      [IQR: 0.16\u20130.34]). Among these patients, 475 had PCa and 341 had csPCa. The mean optimal thresholds for TZ\u2010PSAD and PZ\u2010PSAD were 0.20\u2009ng\/mL\n                      <jats:sup>2<\/jats:sup>\n                      and 0.21\u2009ng\/mL\n                      <jats:sup>2<\/jats:sup>\n                      , respectively, for PCa, whereas they were 0.26 and 0.23, respectively, for csPCa. Multivariable LR identified TZ\u2010PSAD (OR\u2009=\u20092.00,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.03) and WG\u2010PSAD (OR\u2009=\u20092.40,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.02) as significant predictors of PCa. For csPCa, TZ\u2010PSAD was the only independent predictor (OR\u2009=\u20092.13,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.02) among PSAD measurements. TZ\u2010PSAD showed a superior AUC for both PCa (0.79\u2009\u00b1\u20090.05) and csPCa (0.77\u2009\u00b1\u20090.02) compared to WG\u2010PSAD (0.77\u2009\u00b1\u20090.06 for PCa, 0.76\u2009\u00b1\u20090.03 for csPCa) and PZ\u2010PSAD (0.69\u2009\u00b1\u20090.06 for PCa, 0.70\u2009\u00b1\u20090.04 for csPCa;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Both TZ\u2010PSAD and WG\u2010PSAD are strong predictors of PCa, but TZ\u2010PSAD is a superior predictor of csPCa compared to WG\u2010PSAD and PZ\u2010PSAD. Further prospective studies are warranted to validate these findings.<\/jats:p>\n                    <jats:p>\n                      <jats:bold>Trial Registration:<\/jats:bold>\n                      NCT03354416.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/pros.24863","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T01:43:24Z","timestamp":1740534204000},"page":"612-624","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Assessing the Impact of Transition and Peripheral Zone PSA Densities Over Whole\u2010Gland PSA Density for Prostate Cancer Detection on Multiparametric MRI"],"prefix":"10.1002","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3084-4285","authenticated-orcid":false,"given":"Omer Tarik","family":"Esengur","sequence":"first","affiliation":[{"name":"Molecular Imaging Branch National Cancer Institute, National Institutes of Health Bethesda Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7047-1739","authenticated-orcid":false,"given":"Emma","family":"Stevenson","sequence":"additional","affiliation":[{"name":"Molecular Imaging Branch National Cancer Institute, National Institutes of Health Bethesda Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hunter","family":"Stecko","sequence":"additional","affiliation":[{"name":"Molecular Imaging Branch National Cancer Institute, National Institutes of Health Bethesda Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan S.","family":"Lay","sequence":"additional","affiliation":[{"name":"Molecular Imaging Branch National Cancer Institute, National Institutes of Health Bethesda Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Yang","sequence":"additional","affiliation":[{"name":"NVIDIA Corporation Santa Clara California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Tetreault","sequence":"additional","affiliation":[{"name":"NVIDIA Corporation Santa Clara California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyue","family":"Xu","sequence":"additional","affiliation":[{"name":"NVIDIA Corporation Santa Clara California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daguang","family":"Xu","sequence":"additional","affiliation":[{"name":"NVIDIA Corporation Santa Clara California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enis C.","family":"Yilmaz","sequence":"additional","affiliation":[{"name":"Molecular Imaging Branch National Cancer Institute, National Institutes of Health Bethesda Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4317-2561","authenticated-orcid":false,"given":"David G.","family":"Gelikman","sequence":"additional","affiliation":[{"name":"Molecular Imaging Branch National Cancer Institute, National Institutes of Health Bethesda Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2507-2399","authenticated-orcid":false,"given":"Stephanie A.","family":"Harmon","sequence":"additional","affiliation":[{"name":"Molecular Imaging Branch National Cancer Institute, National Institutes of Health Bethesda Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Merino","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology National Cancer Institute, National Institutes of Health Bethesda Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Gurram","sequence":"additional","affiliation":[{"name":"Urologic Oncology Branch National Cancer Institute, National Institutes of Health Bethesda Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford J.","family":"Wood","sequence":"additional","affiliation":[{"name":"Center for Interventional Oncology National Cancer Institute, National Institutes of Health Bethesda Maryland USA"},{"name":"Department of Radiology Clinical Center, National Institutes of Health Bethesda Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter L.","family":"Choyke","sequence":"additional","affiliation":[{"name":"Molecular Imaging Branch National Cancer Institute, National Institutes of Health Bethesda Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Pinto","sequence":"additional","affiliation":[{"name":"Urologic Oncology Branch National Cancer Institute, National Institutes of Health Bethesda Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0853-6494","authenticated-orcid":false,"given":"Baris","family":"Turkbey","sequence":"additional","affiliation":[{"name":"Molecular Imaging Branch National Cancer Institute, National Institutes of Health Bethesda Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21820"},{"key":"e_1_2_11_3_1","volume-title":"Prostate Cancer Screening","author":"Jain M. A.","year":"2024"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2015.05.032"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euros.2022.01.006"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.11.043"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801993"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.5667"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2017.03.039"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13081985"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.4103\/ua.ua_22_22"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-024-04301-z"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2011.06.012"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2019.108660"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.02.033"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.12.9712"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.19.22347"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000530"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2018.09.001"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.13465"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2017.03.130"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2018.08.046"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-024-03420-7"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76786-9"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-020-00717-z"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1590\/S1677-5538.IBJU.2017.0506"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08216-6"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.4103\/aja.aja_72_20"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-36602-x"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.12954\/PI.13022"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2007.04.002"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2008.01.033"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1590\/S1677-55382007000200004"},{"issue":"3","key":"e_1_2_11_34_1","first-page":"320","article-title":"PSA Density and PSA Transition Zone Density in the Diagnosis of Prostate Cancer in PSA Gray Zone Cases","volume":"33","author":"Aksoy Y.","year":"2003","journal-title":"Annals of Clinical and Laboratory Science"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(99)00153-3"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)62911-2"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)64961-9"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-024-10700-z"}],"container-title":["The Prostate"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pros.24863","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T08:37:02Z","timestamp":1748767022000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pros.24863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1002\/pros.24863"],"URL":"https:\/\/doi.org\/10.1002\/pros.24863","archive":["Portico"],"relation":{},"ISSN":["0270-4137","1097-0045"],"issn-type":[{"value":"0270-4137","type":"print"},{"value":"1097-0045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]},"assertion":[{"value":"2024-11-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}